Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Subscriptions

Subscriber Registration

Guidelines for Website Users

E-mail Alert Service

Contact Info

Abnormal Responses to Endothelial Agonists in Raynaud's Phenomenon and Scleroderma

ROBERT R. FREEDMAN, REDA GIRGIS, and MAUREEN D. MAYES

ABSTRACT.

Objective.
To further specify the site of vascular dysfunction in patients with Raynaud's phenomenon (RP) and scleroderma.

Methods. Ten patients with RP and scleroderma and 11 healthy control subjects received brachial artery infusions of sodium nitroprusside, an endothelium independent vasodilator, bradykinin, and substance P while bilateral finger blood flow was measured with venous occlusion plethysmography.

Results. Both groups showed vasodilation to sodium nitroprusside. However, in response to the endothelium dependent compounds bradykinin and substance P, the controls showed vasodilation, whereas the patients showed vasoconstriction.

Conclusion. The vascular defect in RP and scleroderma does not lie at the site of the muscarinic receptor, but possibly in a distal signaling mechanism. (J Rheumatol 2001;28:119-21)

Key Indexing Terms:

SCLERODERMA
RAYNAUD'S PHENOMENON
ENDOTHELIUM
BLOOD VESSELS



Return to January 2001 Table of Contents



© 2001. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.